Product Information
ASENAPINE 5 MG TABLET SL is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $2.0325 per EA under NDC 62332019860. Its NADAC has been published 290 times since Mar 17, 2021.
FDA first approved this application on Dec 10, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332019860
Classification
Generic
Dosage Form
TABLET
Route
SUBLINGUAL
Effective Date
9/23/2026
Active Ingredients
ASENAPINEApproval Type
Generic (ANDA)
FDA Application
ANDA206098FDA Approved
12/10/2020
TE Code
AB
On Market Since
12/10/2020
Pharmacological Classes
Price Statistics
The NADAC for ASENAPINE 5 MG TABLET SL has been published 290 times since Mar 17, 2021, and over the history we have for it it has declined 50.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0325 per EA |
|---|---|
| All-time high | $6.2457 (May 12, 2021) |
| All-time low | $1.7475 (Nov 20, 2024) |
| 52-week high | $2.5136 |
| 52-week low | $2.0325 |
| Median price | $2.7766 |
| Average price | $3.0060 |
| Largest weekly change | +54.8% (Aug 18, 2021) |
| Weeks tracked | 290 |
| Tracking since | Mar 17, 2021 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Asenapine market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ASENAPINE 5 MG TABLET SL?
The current National Average Drug Acquisition Cost (NADAC) for ASENAPINE 5 MG TABLET SL, manufactured by Alembic Pharmaceuticals Inc., is $2.0325 per EA (NDC 62332019860), effective Sep 30, 2026.
How has the price of ASENAPINE 5 MG TABLET SL changed over time?
Over the history we have for it, the NADAC for ASENAPINE 5 MG TABLET SL has declined 50.6%. It has been tracked across 290 weekly CMS publications since Mar 17, 2021.
What are the highest and lowest recorded NADAC prices for ASENAPINE 5 MG TABLET SL?
Since Mar 17, 2021, the NADAC for ASENAPINE 5 MG TABLET SL has ranged from a low of $1.7475 (Nov 20, 2024) to a high of $6.2457 (May 12, 2021), with a median of $2.7766 per EA.
Are there cheaper alternatives to ASENAPINE 5 MG TABLET SL?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as ASENAPINE 5 MG TABLET SL in a comparable dosage form, but none are currently priced below it.
Who manufactures ASENAPINE 5 MG TABLET SL?
ASENAPINE 5 MG TABLET SL (NDC 62332019860) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.